AI Analysis AI Analysis of AMPH AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add AMPH to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Green day on Monday for Amphastar Pharmaceuticals stock after gaining 3.04%
(Updated on Jul 13, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 10, 2026 Gain 3.04%

The Amphastar Pharmaceuticals stock price gained 3.04% on the last trading day (Monday, 13th Jul 2026), rising from $18.72 to $19.29. During the last trading day the stock fluctuated 3.75% from a day low at $18.95 to a day high of $19.66. The price has fallen in 7 of the last 10 days and is down by -11.43% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 70 thousand more shares were traded than the day before. In total, 375 thousand shares were bought and sold for approximately $7.23 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.33% during the next 3 months and, with a 90% probability hold a price between $14.00 and $20.28 at the end of this 3-month period.

AMPH Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, July 10, 2026, and so far it has risen 3.04%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Amphastar Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $19.32 and $19.50. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Amphastar Pharmaceuticals stock

Amphastar Pharmaceuticals finds support from accumulated volume at $19.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.710 between high and low, or 3.75%. For the last week, the stock has had daily average volatility of 3.81%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AMPH) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Amphastar Pharmaceuticals to open at $19.30, and during the day (based on 14 day Average True Range), to move between $18.84 and $19.74, which gives a possible trading interval of +/-$0.91 (+/-4.81%) up or down from last closing price. If Amphastar Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 4.81% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $19.41 (0.62%) than the support at $19.00 (1.50%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Amphastar Pharmaceuticals stock A Buy?

Amphastar Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -1.676 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $19.30 ( 0.0518%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

AMPH Performance

Trading levels for AMPH

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 20.01 3.73%
R2 19.74 2.33%
R1 19.57 1.46%
Price 19.29
S1 19.03 -1.35%
S2 18.86 -2.22%
S3 18.59 -3.63%

Accumulated Volume Support & Resistance Levels

Level Price
R3 19.96 3.47%
R2 19.74 2.33%
R1 19.41 0.622%
Price 19.29
S1 19.00 -1.50%
S2 18.81 -2.49%
S3 18.16 -5.86%

AMPH Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jun 07, 2010 Jun 11, 2010 Jun 30, 2010 $0.300 0%
2 Jun 05, 2009 Jun 11, 2009 Jun 30, 2009 $0.300 0%

FAQ

What is the symbol for Amphastar Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Amphastar Pharmaceuticals is AMPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Amphastar Pharmaceuticals Stock?
Amphastar Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Amphastar Pharmaceuticals Stock?
Amphastar Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Amphastar Pharmaceuticals Stock.

What's the current price of Amphastar Pharmaceuticals Stock?
As of the end of day on the Jul 13, 2026, the price of an Amphastar Pharmaceuticals (AMPH) share was $19.29.

What is the 52-week high and low for Amphastar Pharmaceuticals Stock?
The 52-week high for Amphastar Pharmaceuticals Stock is $31.26 and the 52-week low is $16.65.

What is the market capitalization of Amphastar Pharmaceuticals Stock?
As of the Jul 13, 2026, the market capitalization of Amphastar Pharmaceuticals is 850.552M.

When is the next earnings date for Amphastar Pharmaceuticals?
The upcoming earnings date for Amphastar Pharmaceuticals is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT AMPHASTAR PHARMACEUTICALS
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Eno...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE